| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |